HKD 3.58
(-0.56%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -15.03 Million USD | 84.08% |
2022 | -94.47 Million USD | 53.91% |
2021 | -204.95 Million USD | -104.46% |
2020 | -100.24 Million USD | -1158.68% |
2019 | -7.96 Million USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -7.31 Million USD | 112.3% |
2024 Q1 | -7.31 Million USD | 51.36% |
2023 FY | -15.03 Million USD | 84.08% |
2023 Q2 | -47.22 Million USD | -138.4% |
2023 Q1 | -19.8 Million USD | 79.03% |
2023 Q4 | -15.03 Million USD | -204.2% |
2023 Q3 | 14.43 Million USD | 130.57% |
2022 Q2 | -160.95 Million USD | -10.76% |
2022 Q1 | -145.31 Million USD | 29.1% |
2022 FY | -94.47 Million USD | 53.91% |
2022 Q4 | -94.47 Million USD | -40.83% |
2022 Q3 | -67.08 Million USD | 58.32% |
2021 Q3 | -169.55 Million USD | 0.0% |
2021 FY | -204.95 Million USD | -104.46% |
2021 Q4 | -204.95 Million USD | -20.88% |
2021 Q1 | 103.12 Million USD | 202.87% |
2020 Q4 | -100.24 Million USD | 0.0% |
2020 FY | -100.24 Million USD | -1158.68% |
2019 FY | -7.96 Million USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | -76.36 Million HKD | 80.307% |
CK Life Sciences Int'l., (Holdings) Inc. | 5.26 Billion HKD | 100.286% |